Stifel Nicolaus Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $45

Stifel Nicolaus maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $77 to $45.

Benzinga · 11/07/2019 15:40

Stifel Nicolaus maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $77 to $45.